Characteristics of Fibrillary Glomerulonephritis


About this study

This study will characterize disease symptons as well as pathology related to proteins for fibrillary glomerulonephritis (FGN).



Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients with FGN diagnosed by renal biopsy or proteomic at the Division of Anatomic Pathology

Exclusion Criteria: 

  • none


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Mariam Alexander, M.D.

Open for enrollment

Contact information:

Mariam Alexander M.D.


More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer